1. Home
  2. WALD vs BDSX Comparison

WALD vs BDSX Comparison

Compare WALD & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$0.97

Market Cap

130.8M

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$11.28

Market Cap

107.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WALD
BDSX
Founded
1988
2005
Country
United Kingdom
United States
Employees
364
N/A
Industry
Package Goods/Cosmetics
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.8M
107.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
WALD
BDSX
Price
$0.97
$11.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$2.00
$32.50
AVG Volume (30 Days)
1.2M
52.6K
Earning Date
03-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
$9.89
$25.26
Revenue Next Year
$4.31
$19.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$0.72
$0.25
52 Week High
$3.22
$20.21

Technical Indicators

Market Signals
Indicator
WALD
BDSX
Relative Strength Index (RSI) 44.33 40.65
Support Level $0.86 $6.00
Resistance Level $2.06 $11.57
Average True Range (ATR) 0.11 1.09
MACD 0.01 -0.13
Stochastic Oscillator 59.75 37.00

Price Performance

Historical Comparison
WALD
BDSX

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: